Page last updated: 2024-10-27

fluoxetine and Ganglioside Storage Diseases

fluoxetine has been researched along with Ganglioside Storage Diseases in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research Excerpts

ExcerptRelevanceReference
"Adult GM2 gangliosidosis is a rare disorder that often presents with both neurological and psychiatric syndromes."2.38Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis. ( Kolodny, EH; Renshaw, PF; Schouten, R; Stern, TA; Welch, C, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Renshaw, PF1
Stern, TA1
Welch, C1
Schouten, R1
Kolodny, EH1

Reviews

1 review available for fluoxetine and Ganglioside Storage Diseases

ArticleYear
Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis.
    Annals of neurology, 1992, Volume: 31, Issue:3

    Topics: Adult; beta-N-Acetylhexosaminidases; Combined Modality Therapy; Depressive Disorder; Electroconvulsi

1992